论文部分内容阅读
目的:观察和总结经皮给药佐治小儿腹泻的临床疗效。方法:选取2009年2月—2010年2月住院患儿330例,随机平分为两组,对照组常规治疗,治疗组在常规治疗基础上加用经皮给药治疗仪治疗。结果:治疗组总有效率为97.0%,对照组总有效率为78.8%,差异具有显著性(P<0.01);治疗组平均止泻时间为(1.6±1.2)d,对照组为(2.5±1.4)d,两组比较差异具有显著性(P<0.01)。结论:经皮给药佐治小儿腹泻可以提高临床疗效,缩短病程,在儿科有广阔的应用前景。
Objective: To observe and summarize the clinical efficacy of transdermal drug administration in treating children with diarrhea. Methods: A total of 330 hospitalized children from February 2009 to February 2010 were randomly divided into two groups. The control group received routine treatment. The treatment group was treated with transdermal therapeutic apparatus based on routine treatment. Results: The total effective rate was 97.0% in the treatment group and 78.8% in the control group, with significant difference (P <0.01). The average antidiarrheal time was (1.6 ± 1.2) days in the treatment group and (2.5 ± 1.4) d, the difference between the two groups was significant (P <0.01). Conclusion: Percutaneous administration of diarrhea in children can improve clinical efficacy and shorten the course of disease, which has broad application prospects in pediatrics.